Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled salbutamol versus placebo for transient tachypnea of the newborn
IRCT20190503043457N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in transient tachypnea of the newborn (TTN) comparing Salbutamol plus routine treatment with Placebo plus routine treatment (2 arms). Primary endpoints: Clinical TTN score, Respiratory rate and 5 more. Started Mar 2018; status: completed.
02
Drugs
salbutamol
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on IRCT20190503043457N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190503043457N1.